Evidence map›Paper›PMID 29444189›Full record

ArticlePLoS pathogens2018

Cross-priming induces immunodomination in the presence of viral MHC class I inhibition.

Elvin J Lauron, Liping Yang, Jabari I Elliott, Maria D Gainey, Daved H Fremont, Wayne M Yokoyama

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Direct Priming of CD8Journal of virology · 2021
    Article
  4. Article
  5. Article
  6. Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Elvin J LauronDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0002-5979-9406
Liping YangDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Jabari I ElliottDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0001-8783-0418
Maria D GaineyDepartment of Biology, Western Carolina University, Cullowhee, North Carolina, United States of America.ORCID 0000-0001-8853-2092
Daved H FremontDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Wayne M YokoyamaDivision of Rheumatology, Washington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0002-0566-7264
Washington University in St. Louis · USWestern Carolina University · US

Funding

T Cell Control by Cowpoxvirus U19AI109948 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 2014 to 2018
$6.4M
NIAID NIH HHS U19 AI109948NIH HHS U19-AI109948
6 · The paper itself

Abstract

Viruses have evolved mechanisms of MHCI inhibition in order to evade recognition by cytotoxic CD8+ T cells (CTLs), which is well-illustrated by our prior studies on cowpox virus (CPXV) that encodes potent MHCI inhibitors. Deletion of CPXV viral MHCI inhibitors markedly attenuated in vivo infection due to effects on CTL effector function, not priming. However, the CTL response to CPXV in C57BL/6 mice is dominated by a single peptide antigen presented by H-2Kb. Here we evaluated the effect of viral MHCI inhibition on immunodominant (IDE) and subdominant epitopes (SDE) as this has not been thoroughly examined. We found that cross-priming, but not cross-dressing, is the main mechanism driving IDE and SDE CTL responses following CPXV infection. Secretion of the immunodominant antigen was not required for immunodominance. Instead, immunodominance was caused by CTL interference, known as immunodomination. Both immunodomination and cross-priming of SDEs were not affected by MHCI inhibition. SDE-specific CTLs were also capable of exerting immunodomination during primary and secondary responses, which was in part dependent on antigen abundance. Furthermore, CTL responses directed solely against SDEs protected against lethal CPXV infection, but only in the absence of the CPXV MHCI inhibitors. Thus, both SDE and IDE responses can contribute to protective immunity against poxviruses, implying that these principles apply to poxvirus-based vaccines.

Indexed as

AnimalsAntigens, ViralCells, CulturedChlorocebus aethiopsCross-PrimingEpitopes, T-LymphocyteHeLa CellsHistocompatibility Antigens Class IHumansImmunodominant EpitopesMiceMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicT-Lymphocytes, CytotoxicVero CellsAntigens, ViralEpitopes, T-LymphocyteHistocompatibility Antigens Class IImmunodominant Epitopes

Identifiers

PMID29444189
PMCPMC5812664
OpenAlexW2786115690

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.